This study evaluates the optical quality and clinical performance of the Asqelioâ„¢ EDOF Toric intraocular lens (IOL) in patients undergoing cataract surgery or refractive lensectomy. The Asqelioâ„¢ EDOF Toric IOL aims to provide improved vision at various distances and correct astigmatism compared to monofocal IOLs. Postoperative outcomes, including visual clarity, refractive correction, and patient satisfaction, will be assessed three months after surgery.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Ocular dispersion index (OSI)
Timeframe: Three months after intraocular lens implantation
Higher order aberrations Root Mean Square (HORMS)
Timeframe: Three months after intraocular lens implantation
Ocular Spherical Aberration
Timeframe: Three months after intraocular lens implantation